Bowel perforation in morbid obesity secondary to COVID-19 infection
- 19 November 2021
- journal article
- case report
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 35 (2) , 202-203
Abstract
The pathophysiology of SARS-CoV-2 is unique in the different pathways the virus utilizes to induce severe systemic inflammation, leading to a higher potential for critical care requirements and a poorer prognosis. Although there are several risk factors for the development of severe infection, one associated with poorer outcome is obesity. In this report, we present a case of bowel perforation in an obese patient with severe COVID-19 infection.Keywords
This publication has 7 references indexed in Scilit:
- The first 12 months of COVID-19: a timeline of immunological insightsNature Reviews Immunology, 2021
- Immune Response, Inflammation, and the Clinical Spectrum of COVID-19Frontiers in Immunology, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital AdmissionClinical Infectious Diseases, 2020
- Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirusAnnals of Palliative Medicine, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004